Monte Rosa Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$15.71

+0.99 (+6.73%)

As of Mar 25, 10:01 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +144.7% upside

Low Target $28.40

Average Target $38.45

High Target $50.36

Current Price $15.71

Current
$15.71

Target
$38.45

$28.40 $38.45 avg $50.36

Scenario Analysis

Bear Case

$28.40

80.8%

Low target

Base Case

$38.45

+144.7%

Avg target

Bull Case

$50.36

+220.6%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$25.77

-39.0% from high

52-Week Low

$3.50

+348.8% from low

Target vs 52W High

$38.45

+49.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%